PT  - JOURNAL ARTICLE
AU  - Coupe, Nicholas
AU  - Pinato, David J
AU  - Fairchild, Justin
AU  - Poe, Russell
AU  - Browne, Carri
AU  - Innaimo, Steven
AU  - Thompson, David
AU  - Gileadi, Uzi
AU  - Santo, Carmela De
AU  - Kramer, Robert
AU  - Walters, Ian
AU  - Middleton, Mark R
TI  - 712 IMPORT-201 (IMP-MEL): a phase 1 first-in-human dose finding/randomized phase 2 study of a novel iNKT agonist (PORT-2) and pembrolizumab for advanced melanoma and non-small cell lung cancer (NSCLC)
AID  - 10.1136/jitc-2023-SITC2023.0712
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A807--A807
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A807.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A807.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.